Nathypharm SRL
Nathypharm reported total assets of 340,634 € at the end of the 2024 financial year (annual accounts filed with the NBB on 01 Oct 2025).
The score of Nathypharm shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Change 2021 → 2024: Equity +83 % Total assets +423 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Nathypharm's annual accounts
| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Net result | −47,903 € | ||||
| Equity | 65,374 € | ||||
| Cash | 7,130 € | ||||
| EBITDA | −6,656 € | ||||
| Total assets | 340,634 € |
Filed annual accounts
- Year ended 31 Dec 2024filed on 01 Oct 2025
- Year ended 30 Jun 2023filed on 09 Jan 2024
- Year ended 30 Jun 2022filed on 31 Jan 2023
- Year ended 30 Jun 2021filed on 13 Jan 2022
- Year ended 30 Jun 2020filed on 11 Jan 2021
Nathypharm's financial analysis
- Solvency19.2%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Nathypharm
Nathypharm's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0837.507.106
- VAT number
- BE0837507106
- Peppol
- Registered · 0208:0837507106 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 04 Jul 2011
- Registered office
- 5300 Andenne
- Latest accounts
- 2024 · filed on 01 Oct 2025
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Nathypharm (SRL) has been based in Andenne since 2011, active in: retail sale of pharmaceutical products. For 2024, it reports a net loss of 47,903 € and equity of 65,374 €; its revenue is not published. Its solvency stands at 19.2%, below the median of its sector (41.5%).
Companies similar to Nathypharm
Companies in the same business, of comparable size and area, outside its group.
- Pharma pour Tous Namur Retail sale of pharmaceutical products Namur · balance sheet 340,936 €
- Apotheek Alaerts Retail sale of pharmaceutical products Leopoldsburg · balance sheet 341,263 €
- Pharmaline Retail sale of pharmaceutical products Courcelles · balance sheet 339,554 €
- Sogephar Retail sale of pharmaceutical products Ixelles · balance sheet 337,204 €
- Alsempharma Retail sale of pharmaceutical products Beersel · balance sheet 336,894 €
- Phardec Retail sale of pharmaceutical products Koekelberg · balance sheet 335,635 €
- Almax Pharma Retail sale of pharmaceutical products Walcourt · balance sheet 346,656 €
- Immo Maeriën-Ghilain Retail sale of pharmaceutical products Kasterlee · balance sheet 348,075 €
Frequently asked questions about Nathypharm
What is the revenue of Nathypharm?
Nathypharm files its accounts in a format where revenue is optional: it is not published for 2024.
What is the VAT number of Nathypharm?
In Belgium, the VAT number is the company number prefixed with BE: BE0837507106 for Nathypharm, if the company is VAT-registered. Its company number (CBE) is 0837.507.106.
Where is the registered office of Nathypharm?
According to the CBE register, the registered office of Nathypharm is in 5300 Andenne.
What is the equity of Nathypharm?
At the close of the 2024 financial year, the equity of Nathypharm amounts to 65,374 €, a solvency of 19.2% of total assets.
Who manages Nathypharm?
The register lists 2 active mandates at Nathypharm. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Nathypharm
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →